Linda-isabell Schmitt
Essen, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Immune Cell-Specific SMN Expression and Sustained Immune Alterations in Treated Spinal Muscular Atrophy.
Journal: The Journal of clinical investigation
Published: August 25, 2026
Choosing the optimal mouse model for the study of late-onset spinal muscular atrophy: Why the 4-copy SMN2 model offers ideal translational relevance.
Journal: Journal of neuromuscular diseases
Published: January 16, 2026
Proteomic profiles in inclusion body myositis and polymyositis with mitochondrial pathology.
Journal: Acta neuropathologica communications
Published: November 10, 2025
Matched-pair analysis of motor outcomes in adults with spinal muscular atrophy on nusinersen vs. risdiplam.
Journal: Journal of neurology
Published: November 03, 2025
Combined Histological and Proteomic Analysis Reveals Muscle Denervation in KMT5B-Related Neurodevelopmental Disorder: A Case Report.
Journal: Journal of clinical medicine
Published: October 21, 2025
Reverse engineering of BNIP3 identifies a mitochondrial protective peptide.
Journal: Nature communications
Published: August 05, 2025
Neuronal Pentraxin 2 as a Potential Biomarker for Nusinersen Therapy Response in Adults with Spinal Muscular Atrophy: A Pilot Study.
Journal: Biomedicines
Published: June 24, 2025
Results of the preclinical multicenter randomized controlled paclitaxel-induced neuropathy prevention replication study (PINPRICS).
Journal: BMC research notes
Published: August 08, 2024
Triiodothyronine treatment in mice improves stroke outcome and reduces blood-brain barrier damage.
Journal: European thyroid journal
Published: May 08, 2024
Last Updated: 09/26/2026